Mutations in btk in patients with presumed X-linked agammaglobulinemia.
about
A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humansTargeting neoplastic B cells and harnessing microenvironment: the "double face" of ibrutinib and idelalisibFunctional interaction of caveolin-1 with Bruton's tyrosine kinase and BmxA spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnessesNext Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders - Future Directions.Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer.Early B cell defects.Mutations in Igalpha (CD79a) result in a complete block in B-cell development.Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia.Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.Clinical and molecular analysis of patients with defects in micro heavy chain gene.Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient.Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100.Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K.Genetic analysis of patients with defects in early B-cell development.Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myelomaStability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemiaRespiratory Health and Related Quality of Life in Patients with Congenital Agammaglobulinemia in the Northern Region of the UK.The genetic theory of infectious diseases: a brief history and selected illustrations.A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells.Genetics of hypogammaglobulinemia: what do we really know?Clinical consequences of defects in B-cell development.Immune diseases caused by mutations in kinases and components of the ubiquitin system.Dissecting Epigenetic Dysregulation of Primary Antibody Deficiencies.X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements.A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease.Genes required for B cell development.Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing.BTK mutations selectively regulate BTK expression and upregulate monocyte XBP1 mRNA in XLA patientsxid mice reveal the interplay of homeostasis and Bruton's tyrosine kinase-mediated selection at multiple stages of B cell development.Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1.A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness.Clinical features and mutation analysis of X-linked agammaglobulinemia in 20 Chinese patients.Role of Bruton's tyrosine kinase in macrophage apoptosis.Mutations of Bruton's tyrosine kinase gene in Brazilian patients with X-linked agammaglobulinemia.
P2860
Q24301360-5B6FA305-0F77-403A-8398-9DD73326CD53Q27025812-325302BE-7010-4CEF-91E8-1465BB74D7D2Q28212744-6A48FF34-C184-486A-890A-BC7597BD2419Q28216635-115D4524-8D5E-4781-8B31-70A13207237AQ31060798-8CEF033E-0D81-4E4B-8B7F-A1060714B737Q33602552-AFFA0C37-EE7C-4CF4-ABF8-5575CD051E45Q33848541-2A52A461-EBB8-4677-AF8C-B8010E783BFDQ33859540-11EB8EC1-AA98-4773-A39B-ED107FE3AB62Q34121038-030E6D25-00F8-45B1-9DBB-4B033D2C4D5FQ34386319-AD2FC771-1E25-42BA-BF99-110C733C1841Q34798196-04C63BC4-8632-40B9-8DD4-4499156919EFQ35001259-8B9807FF-B30D-4735-80B7-26FAD6AC3DEDQ35062895-4FBADC76-7829-4D2A-BAC1-8ACEB29990AAQ35825989-F95073E6-2C9E-417A-8619-ECDB638BDB33Q36015046-D4C27551-BCE6-4C1F-ACB9-2AEDFD393548Q36206430-F70E47A8-3F38-4BB9-A64E-300FD21C1520Q36281810-C953EEF2-0123-4132-967E-9C00B8BD541FQ36978830-0636D3E3-5A30-450F-9B7C-CBADFEC94DF4Q37166962-8B87A924-6BE2-4186-BE1F-71FA2168FDEBQ37259320-87374531-DCE1-43F9-B5C0-7C45B491C030Q37571008-6E84251D-4441-4D8F-ADDC-41E850BCF1C0Q37725430-DFE25C6B-50AC-4159-9A76-916EA440E77BQ38212818-C35DF9E5-311C-4FC7-8AD0-9BC5478723B5Q38777804-8783F33B-E57C-4051-9128-63C5A7FDD9BBQ38851997-5EDD8D4F-3862-489C-B9EA-42B127D50E76Q39141906-EAC17EA7-84BD-40DE-8EBE-C2D3B24320A4Q40017955-6C9749A2-DDDD-4F30-8F22-B62C231FFBB5Q40271553-82B2EDAD-7948-4C57-8D96-408EC94CE438Q40323773-5E0E1DEE-159B-4FA6-9679-E625BAC3649BQ40488148-108D5173-B652-4471-BC00-B46A931B86CDQ43805222-7FE9867C-B617-4480-BE16-85A4727E495EQ49605266-A034F306-F7F0-443B-A3A9-5578BD5CE793Q50491845-59C02CBF-0501-4469-8473-114CA73A6243Q51279362-A0DB108B-A8DD-4039-8A3D-A7D907EFB322Q54623328-E4C05150-9ED8-4807-8D21-E0D45EDAB66CQ54655314-06EA7324-0F31-4455-A887-5D5B7562C1A3
P2860
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@ast
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@en
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@nl
type
label
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@ast
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@en
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@nl
prefLabel
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@ast
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@en
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@nl
P2093
P2860
P356
P1476
Mutations in btk in patients with presumed X-linked agammaglobulinemia.
@en
P2093
J Treadaway
M E Conley
Y Minegishi
P2860
P304
P356
10.1086/301828
P407
P577
1998-05-01T00:00:00Z